Drug Safety

, Volume 32, Issue 4, pp 275–282 | Cite as

How do we Safely Treat Depression in Children, Adolescents and Young Adults?

Current Opinion

Abstract

Increasing concerns about the safety and efficacy of antidepressant drugs for children, adolescents and young adults have been countered by claims that reduced prescribing of antidepressants may have dangerous consequences. This leaves clinicians unsure as to how to weigh up the evidence and apply it to their patients. This paper promotes an approach of evaluating the evidence in each study according to the importance of the outcomes being measured in that study. It finds that on important measures such as mortality, hospitalization and quality of life, the evidence is unfavourable for antidepressants in this population. Here, an approach is suggested that primary care physicians might adopt with their depressed young patients. Through a combination of ‘watchful waiting’ and physical and emotional rehabilitation, physicians can actively intervene without reliance on medication or psychotherapy.

References

  1. 1.
    Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54: 1031–7PubMedCrossRefGoogle Scholar
  2. 2.
    Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 762–72PubMedCrossRefGoogle Scholar
  3. 3.
    Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41: 1205–15PubMedCrossRefGoogle Scholar
  4. 4.
    Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003; 290: 1033–41PubMedCrossRefGoogle Scholar
  5. 5.
    Jureidini J, Doecke C, Mansfield P, et al. Efficacy and safety of antidepressants for children and adolescents. BMJ 2004; 328: 879–83PubMedCrossRefGoogle Scholar
  6. 6.
    Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341–5PubMedCrossRefGoogle Scholar
  7. 7.
    Hammad TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 2006; 26: 203–7PubMedCrossRefGoogle Scholar
  8. 8.
    Treatment for Adolescents with Depression Study Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) Randomized Controlled Trial. JAMA 2004; 292: 807–20CrossRefGoogle Scholar
  9. 9.
    Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007 Apr 18; 297(15): 1683–96PubMedCrossRefGoogle Scholar
  10. 10.
    Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164: 1356–63PubMedCrossRefGoogle Scholar
  11. 11.
    Brent DA. Antidepressants and pediatric depression: the risk of doing nothing. N Engl J Med 2004 Oct 14; 351(16): 1598–601PubMedCrossRefGoogle Scholar
  12. 12.
    Mansfield PR. Trials of newer antidepressants for depressed children and/or adolescents [online]. Available from URL: http://www.healthyskepticism.org/documents/documents/trialstable.php [Accessed 2008 Nov]
  13. 13.
    Morgan S, Bassett K, Mintzes B. Outcomes-based drug coverage in British Columbia. Health Aff (Millwood) 2004 May–Jun; 23(3): 269–76CrossRefGoogle Scholar
  14. 14.
    Tiihonen J, Lönnqvist J, Wahlbeck K, et al. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006 Dec; 63(12): 1358–67PubMedCrossRefGoogle Scholar
  15. 15.
    Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry 2006 Aug; 63(8): 865–72PubMedCrossRefGoogle Scholar
  16. 16.
    Wheeler BW, Gunnell D, Metcalfe C, et al. The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. BMJ 2008 Mar 8; 336(7643): 542–5PubMedCrossRefGoogle Scholar
  17. 17.
    March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007 Oct; 64(10): 1132–43PubMedCrossRefGoogle Scholar
  18. 18.
    Hamilton M. A rating scale for depression. J Neurol Psychiatry 1960; 23: 56–9CrossRefGoogle Scholar
  19. 19.
    Poznanski EO, Mokros H. Children’s Depression Rating Scale Revised (CDRS-R). Los Angeles (CA): Western Psychological Services, 1996Google Scholar
  20. 20.
    Morgan S, Bassett K, Mintzes B. An outcomes-based approach to decisions about drug coverage policies in British Columbia. Psychiatr Serv 2004 Nov; 55(11): 1230–2PubMedCrossRefGoogle Scholar
  21. 21.
    Fombonne E, Wostear G, Cooper V, et al. The Maudsley long-term follow-up of child and adolescent depression: 2. Suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry 2001 Sep; 179: 218–23PubMedCrossRefGoogle Scholar
  22. 22.
    Shaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996 Apr; 53(4): 339–48PubMedCrossRefGoogle Scholar
  23. 23.
    Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 2004 May; 49(5): 303–9PubMedGoogle Scholar
  24. 24.
    Fergusson DM, Horwood LJ, Ridder EM, et al. Suicidal behaviour in adolescence and subsequent mental health outcomes in young adulthood. Psychol Med 2005 Jul; 35(7): 983–93PubMedCrossRefGoogle Scholar
  25. 25.
    Mosholder AD, Willy M. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. J Child Adolesc Psychopharmacol 2006 Feb–Apr; 16(1–2): 25–32PubMedCrossRefGoogle Scholar
  26. 26.
    Mann JJ, Emslie G, Baldessarini RJ, et al. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 2006 Mar; 31(3): 473–92PubMedCrossRefGoogle Scholar
  27. 27.
    SmithKline Beecham. A multi-center, double-blind, placebo controlled study of paroxetine and imipramine in adolescents with unipolar major depression: acute phase. Final clinical report. SB document number: BRL-029060/RSD-100TW9/ 1/CPMS-329, 24 Nov 1998, p. 277 [online]. Available from URL: http://www.gsk.com/media/paroxetine/depression_329_full.pdf [Accessed 2008 Jun 23]
  28. 28.
    Emslie GJ, Findling RL, Yeung PP, et al. ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2007 Apr; 46(4): 479–88PubMedCrossRefGoogle Scholar
  29. 29.
    US Food and Drug Administration. FDA issues public health advisory on cautions for use of antidepressants in adults and children March 22, 2004 [online]. Available from URL: http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01283.html [Accessed 2008 Nov 28]
  30. 30.
    Wagner KD, Robb AS, Findling RL, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004; 161: 1079–83PubMedCrossRefGoogle Scholar
  31. 31.
    Berard R, Fong R, Carpenter DJ, et al. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006; 16: 59–75PubMedCrossRefGoogle Scholar
  32. 32.
    Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, doubleblind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006; 45: 709–19PubMedCrossRefGoogle Scholar
  33. 33.
    Von Knorring AL, Olsson GI, Thomsen PH, et al. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006; 26: 311–5CrossRefGoogle Scholar
  34. 34.
    Wagner KD, Jonas J, Findling RL, et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006; 45: 280–8PubMedCrossRefGoogle Scholar
  35. 35.
    Tsapakis ME, Soldani F, Tondo L, et al. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008; 193: 10–7PubMedCrossRefGoogle Scholar
  36. 36.
    Jureidini J, Tonkin A, Mansfield P. TADS study raises concerns [letter]. BMJ 2004; 329: 1343CrossRefGoogle Scholar
  37. 37.
    Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008 Feb; 5(2): e45PubMedCrossRefGoogle Scholar
  38. 38.
    Kirsch I, Moore TJ, Scoboria A, et al. The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prev Treat 2002, Vol. 5, article 23 [online]. Available from URL: http://www.journals.apa.org/prevention/volume5/pre0050023a.html. [Accessed 2007 Jul 1]
  39. 39.
    Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008 Jan 17; 358(3): 252–60PubMedCrossRefGoogle Scholar
  40. 40.
    Deshauer D, Moher D, Fergusson D, et al. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ 2008 May 6; 178(10): 1293–301PubMedCrossRefGoogle Scholar
  41. 41.
    Shearer M, Bermingham SL. The ethics of paediatric antidepressant use: erring on the side of caution. J Med Ethics 2008 Oct; 34(10): 710–4PubMedCrossRefGoogle Scholar
  42. 42.
    The National Collaborating Centre for Mental Health. CG28 depression in children and young people: full guideline [online]. Available from URL: http://www.nice.org.uk/guidance/index.jsp?action=download&o=29859 [Accessed 2008 Jun]
  43. 43.
    Wakefield JC, Schmitz MF, First MB, et al. Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. Arch Gen Psychiatry 2007 Apr; 64(4): 433–40PubMedCrossRefGoogle Scholar
  44. 44.
    Spijker J, de Graaf R, Bijl RV, et al. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002 Sep; 181: 208–13PubMedCrossRefGoogle Scholar
  45. 45.
    Moncrieff J, Cohen D. Do antidepressants cure or create abnormal brain states? PLoS Med 2006; 3(7): e240PubMedCrossRefGoogle Scholar
  46. 46.
    Larun L, Nordheim LV, Ekeland E, et al. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst Rev 2006 Jul 19; (3): CD004691Google Scholar
  47. 47.
    Rivers WHR. Instinct and the unconscious. a contribution to a biological theory of the psycho-neuroses. Cambridge: Cambridge University Press, 1920Google Scholar
  48. 48.
    Smyth JM, Pennebaker JW. Exploring the boundary conditions of expressive writing: in search of the right recipe. Br J Health Psychol 2008; 13: 1–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  1. 1.Department of Psychological Medicine, Children’s, Youth and Women’s Health ServiceWomen’s and Children’s HospitalNorth AdelaideAustralia
  2. 2.Disciplines of Psychiatry and PaediatricsUniversity of AdelaideAdelaideAustralia
  3. 3.Department of PhilosophyFlinders UniversityAustralia

Personalised recommendations